AI assistant
Inogen Inc — Director's Dealing 2022
Mar 4, 2022
33625_dirs_2022-03-03_4210534e-8404-4baf-a194-a71f6be62c39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2022-03-01
Reporting Person: Glezer Stanislav (EVP, Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | Restricted Stock Unit | $ | A | 11360 | Acquired | Common Stock (11360) | Direct | |
| 2022-03-01 | Restricted Stock Unit | $ | A | 11360 | Acquired | Common Stock (11360) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.
F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.